• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.TLR3特异性双链RNA寡核苷酸佐剂可诱导树突状细胞交叉呈递、CTL反应及抗病毒保护作用。
J Immunol. 2011 Feb 15;186(4):2422-9. doi: 10.4049/jimmunol.1002845. Epub 2011 Jan 17.
2
TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.Toll样受体3介导的CD8⁺树突状细胞激活与细胞内抗病毒状态的建立相关联。
J Immunol. 2015 Aug 1;195(3):1025-33. doi: 10.4049/jimmunol.1402033. Epub 2015 Jun 22.
3
Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.直接呈递和交叉呈递在针对单纯疱疹病毒1的细胞毒性T淋巴细胞免疫中的作用。
J Immunol. 2009 Jan 1;182(1):283-92. doi: 10.4049/jimmunol.182.1.283.
4
Broadly Protective CD8 T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine.热休克蛋白 gp96 佐剂流感单价裂解疫苗诱导广泛保护性 CD8 T 细胞免疫应答针对高度保守表位。
J Virol. 2021 May 24;95(12). doi: 10.1128/JVI.00507-21.
5
A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.小肠中 CD103+CD8alpha+树突状细胞的一个新亚群表达 TLR3、TLR7 和 TLR9,并诱导 Th1 反应和 CTL 活性。
J Immunol. 2011 Jun 1;186(11):6287-95. doi: 10.4049/jimmunol.1004036. Epub 2011 Apr 27.
6
Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.朗格汉斯细胞+ CD8α+树突状细胞对于系统性抗原的交叉呈递和 IL-12 的产生至关重要。
J Immunol. 2009 Dec 15;183(12):7732-42. doi: 10.4049/jimmunol.0902707.
7
Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.流感疫苗接种期间RIG-I通路的激活可增强生发中心反应,促进滤泡辅助性T细胞的诱导,并提供剂量节省效应和保护性免疫。
J Virol. 2014 Dec;88(24):13990-4001. doi: 10.1128/JVI.02273-14. Epub 2014 Sep 24.
8
Toll-like receptor 3 promotes cross-priming to virus-infected cells.Toll样受体3促进对病毒感染细胞的交叉启动。
Nature. 2005 Feb 24;433(7028):887-92. doi: 10.1038/nature03326. Epub 2005 Feb 13.
9
A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection.单链寡核苷酸抑制 Toll 样受体 3 激活并减少甲型流感(H1N1)感染。
Front Immunol. 2019 Sep 12;10:2161. doi: 10.3389/fimmu.2019.02161. eCollection 2019.
10
Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.聚腺苷酸:聚尿苷酸通过Toll样受体3和Toll样受体7发挥的免疫佐剂作用。
Int Immunol. 2008 Jan;20(1):1-9. doi: 10.1093/intimm/dxm112. Epub 2007 Nov 1.

引用本文的文献

1
Catch me if you can: viral nucleic acids to host sensors.若你能,就抓住我:病毒核酸与宿主传感器。
Front Immunol. 2025 Jul 28;16:1632283. doi: 10.3389/fimmu.2025.1632283. eCollection 2025.
2
Rewriting the dendritic cell code in cancer-from subset identity to immunotherapeutic design.重编癌症中树突状细胞编码——从亚群特性到免疫治疗设计
FEBS Lett. 2025 Jul;599(14):2060-2083. doi: 10.1002/1873-3468.70108. Epub 2025 Jul 16.
3
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4 and CD8 T-cell responses and neutralizing antibody induction.ARNAX是新冠疫苗增强抗原特异性CD4和CD8 T细胞反应以及诱导中和抗体的理想佐剂。
J Virol. 2025 May 20;99(5):e0229024. doi: 10.1128/jvi.02290-24. Epub 2025 Apr 15.
4
A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors.一项机会窗试验,评估在经皮可及肿瘤患者中瘤内注射考帕松®。
Transl Med Commun. 2023;8. doi: 10.1186/s41231-023-00137-9. Epub 2023 Feb 27.
5
De novo design of protein minibinder agonists of TLR3.Toll样受体3的蛋白质微型结合激动剂的从头设计
Nat Commun. 2025 Jan 31;16(1):1234. doi: 10.1038/s41467-025-56369-w.
6
Cross-priming in cancer immunology and immunotherapy.癌症免疫学与免疫治疗中的交叉呈递
Nat Rev Cancer. 2025 Apr;25(4):249-273. doi: 10.1038/s41568-024-00785-5. Epub 2025 Jan 29.
7
Understanding the impact of transcription byproducts and contaminants.了解转录副产物和污染物的影响。
Front Mol Biosci. 2024 Jul 10;11:1426129. doi: 10.3389/fmolb.2024.1426129. eCollection 2024.
8
Dendritic cells steering antigen and leukocyte traffic in lymph nodes.树突状细胞引导抗原和白细胞在淋巴结中的流动。
FEBS Lett. 2025 Jul;599(14):2048-2059. doi: 10.1002/1873-3468.14982. Epub 2024 Jul 12.
9
MHC class I-dressing is mediated via phosphatidylserine recognition and is enhanced by polyI:C.MHC I类分子修饰通过磷脂酰丝氨酸识别介导,并被聚肌胞苷酸增强。
iScience. 2024 Apr 10;27(5):109704. doi: 10.1016/j.isci.2024.109704. eCollection 2024 May 17.
10
De novo design of protein minibinder agonists of TLR3.Toll样受体3(TLR3)蛋白微型结合激动剂的从头设计
bioRxiv. 2024 Apr 18:2024.04.17.589973. doi: 10.1101/2024.04.17.589973.

本文引用的文献

1
An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.一种佐剂,可在小鼠中诱导针对 H5N1 流感病毒疫苗的有效、保护性体液反应,并具有节省抗原的作用。
J Virol. 2010 Sep;84(17):8639-49. doi: 10.1128/JVI.00596-10. Epub 2010 Jun 10.
2
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells.XC 趋化因子受体 1 是一种保守的选择性哺乳动物细胞标记物,与小鼠 CD8α+树突状细胞同源。
J Exp Med. 2010 Jun 7;207(6):1283-92. doi: 10.1084/jem.20100223. Epub 2010 May 17.
3
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.鉴定人 DNGR-1+BDCA3+ 白细胞为鼠 CD8alpha+ 树突状细胞的假定同系物。
J Exp Med. 2010 Jun 7;207(6):1261-71. doi: 10.1084/jem.20092618. Epub 2010 May 17.
4
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.人 CD141+(BDCA-3)+树突状细胞(DCs)代表了一种独特的髓样 DC 亚群,能够交叉呈递坏死细胞抗原。
J Exp Med. 2010 Jun 7;207(6):1247-60. doi: 10.1084/jem.20092140. Epub 2010 May 17.
5
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.高抗原交叉呈递和 XCR1 表达将人 CD11c+CD141+ 细胞定义为小鼠 CD8+树突状细胞的同源物。
J Exp Med. 2010 Jun 7;207(6):1273-81. doi: 10.1084/jem.20100348. Epub 2010 May 17.
6
Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.外周血 CD103+树突状细胞形成一个统一的亚群,在发育上与 CD8α+传统树突状细胞相关。
J Exp Med. 2010 Apr 12;207(4):823-36. doi: 10.1084/jem.20091627. Epub 2010 Mar 29.
7
Origin and development of dendritic cells.树突状细胞的起源与发展。
Immunol Rev. 2010 Mar;234(1):45-54. doi: 10.1111/j.0105-2896.2009.00879.x.
8
The CD8+ dendritic cell subset.CD8+ 树突状细胞亚群。
Immunol Rev. 2010 Mar;234(1):18-31. doi: 10.1111/j.0105-2896.2009.00870.x.
9
Features of the dendritic cell lineage.树突状细胞谱系的特征。
Immunol Rev. 2010 Mar;234(1):5-17. doi: 10.1111/j.0105-2896.2009.00888.x.
10
Regulation of adaptive immunity by the innate immune system.先天免疫系统对适应性免疫的调节。
Science. 2010 Jan 15;327(5963):291-5. doi: 10.1126/science.1183021.

TLR3特异性双链RNA寡核苷酸佐剂可诱导树突状细胞交叉呈递、CTL反应及抗病毒保护作用。

TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.

作者信息

Jelinek Ivett, Leonard Joshua N, Price Graeme E, Brown Kevin N, Meyer-Manlapat Anna, Goldsmith Paul K, Wang Yan, Venzon David, Epstein Suzanne L, Segal David M

机构信息

Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

J Immunol. 2011 Feb 15;186(4):2422-9. doi: 10.4049/jimmunol.1002845. Epub 2011 Jan 17.

DOI:10.4049/jimmunol.1002845
PMID:21242525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3078629/
Abstract

Maturation of dendritic cells (DC) to competent APC is essential for the generation of acquired immunity and is a major function of adjuvants. dsRNA, a molecular signature of viral infection, drives DC maturation by activating TLR3, but the size of dsRNA required to activate DC and the expression patterns of TLR3 protein in DC subsets have not been established. In this article, we show that cross-priming CD8α(+) and CD103(+) DC subsets express much greater levels of TLR3 than other DC. In resting DC, TLR3 is located in early endosomes and other intracellular compartments but migrates to LAMP1(+) endosomes on stimulation with a TLR3 ligand. Using homogeneous dsRNA oligonucleotides (ONs) ranging in length from 25 to 540 bp, we observed that a minimum length of ∼90 bp was sufficient to induce CD86, IL-12p40, IFN-β, TNF-α, and IL-6 expression, and to mature DC into APC that cross-presented exogenous Ags to CD8(+) T cells. TLR3 was essential for activation of DC by dsRNA ONs, and the potency of activation increased with dsRNA length and varied between DC subsets. In vivo, dsRNA ONs, in a size-dependent manner, served as adjuvants for the generation of Ag-specific CTL and for inducing protection against lethal challenge with influenza virus when given with influenza nucleoprotein as an immunogen. These results provide the basis for the development of TLR3-specific adjuvants capable of inducing immune responses tailored for viral pathogens.

摘要

树突状细胞(DC)成熟为有功能的抗原呈递细胞(APC)对于获得性免疫的产生至关重要,并且是佐剂的主要功能。双链RNA(dsRNA)作为病毒感染的分子标志,通过激活Toll样受体3(TLR3)来驱动DC成熟,但激活DC所需的dsRNA大小以及DC亚群中TLR3蛋白的表达模式尚未明确。在本文中,我们发现交叉呈递的CD8α(+)和CD103(+) DC亚群表达的TLR3水平远高于其他DC。在静息DC中,TLR3位于早期内体和其他细胞内区室,但在用TLR3配体刺激后会迁移至溶酶体相关膜蛋白1(LAMP1)(+)内体。使用长度范围为25至540 bp的均一化dsRNA寡核苷酸(ONs),我们观察到约90 bp的最小长度足以诱导CD86、白细胞介素12p40(IL-12p40)、干扰素-β(IFN-β)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)的表达,并使DC成熟为能够将外源性抗原交叉呈递给CD8(+) T细胞的APC。TLR3对于dsRNA ONs激活DC至关重要,激活效力随dsRNA长度增加而增强,且在DC亚群之间存在差异。在体内,dsRNA ONs以大小依赖的方式作为佐剂,与流感核蛋白作为免疫原一起使用时,可用于产生抗原特异性细胞毒性T淋巴细胞(CTL)并诱导对流感病毒致死性攻击的保护作用。这些结果为开发能够诱导针对病毒病原体的定制免疫反应的TLR3特异性佐剂提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/d9fa02db1b48/nihms262278f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/c1cfbeea72f7/nihms262278f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/78d5bdd3b964/nihms262278f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/13303826a4db/nihms262278f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/919679301896/nihms262278f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/6d6630fcd298/nihms262278f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/34a8a281eb74/nihms262278f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/d9fa02db1b48/nihms262278f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/c1cfbeea72f7/nihms262278f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/78d5bdd3b964/nihms262278f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/13303826a4db/nihms262278f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/919679301896/nihms262278f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/6d6630fcd298/nihms262278f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/34a8a281eb74/nihms262278f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665d/3078629/d9fa02db1b48/nihms262278f7.jpg